Stanford University
Showing 101-200 of 501 Results
-
Fei Dong
Associate Professor of Pathology
BioDr. Dong is the Director of Molecular Pathology at Stanford Health Care. The Molecular Pathology laboratory offers a broad menu of clinical diagnostic tests ranging from PCR to next generation sequencing. Dr. Dong's academic interests include the clinical implementation of laboratory developed tests, the development of novel informatics algorithms, and characterization of disease by molecular methods. Before arriving at Stanford, Dr. Dong was on faculty at Brigham and Women’s Hospital/Harvard Medical School for nine years, where he established a track record in education and mentorship and was the recipient of both the Anatomic Pathology and Clinical Pathology resident teaching awards. Dr. Dong has served on committees for the Association for Molecular Pathology, the Clinical and Laboratory Standards Institute, and the United States and Canadian Academy of Pathology. He serves on the editorial boards of multiple scientific journals and is an Associate Editor for the Journal of Molecular Diagnostics.
-
Alex Maurice Dussaq
Clinical Assistant Professor, Pathology
BioAlex Maurice Dussaq, M.D., Ph.D., is an assistant professor of breast pathology and an associate director of pathology informatics. Dr. Dussaq holds a B.S. in Mathematics and Biochemistry from University of Nevada, Reno and an M.D./Ph.D. from University at Alabama, Birmingham. His Ph.D. focused on novel platform informatics and statistical analysis. He completed a Pathology residency and fellowships at Stanford in breast pathology and clinical informatics. Dr. Dussaq's research interests include the implementation and creation of workflow tools for surgical pathology and lab. He is particularly interested in whole slide image management systems and the future applications of artificial intelligence and large language models in pathology and medicine..
-
Alex Edwin
Life Science Research Professional 1, Pathology - Montine Lab
BioAlex received his bachelor's degree in neuroscience from Santa Clara University. He also minored in Spanish and Biology. During his time there, he studied fMRI data to identify patterns of resting-state functional brain connectivity in individuals with Autism Spectrum Disorder. Currently, he utilizes hippocampal slice cultures, cell cultures, and biochemical assays to screen small molecule drug compounds. His research is conducted with hopes to identify novel therapeutics for Alzheimer's disease, Parkinson's disease, and X-linked creatine deficiency.
-
Ifeanyichukwu Emmanuel Eke
Postdoctoral Scholar, Pathology
BioI am a chemical biologist with a broad interest in defining the mechanisms-of-action of novel compounds that can be used as potential drugs or diagnostic probes for different bacterial and viral infections. In addition to my flair for research, I am passionate about teaching, mentorship, leadership, and entrepreneurship.
-
Lawrence Eng
Professor (Research) of Pathology, Emeritus
Current Research and Scholarly InterestsAstrocytes make up a substantial proportion of the central nervous system (CNS) and participate in a variety of important physiologic and pathologic processes. They are characterized by vigorous response to diverse neurologic insults.
-
Edgar Engleman
Professor of Pathology and of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsDendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.
-
Dean W. Felsher
Professor of Medicine (Oncology) and of Pathology
Current Research and Scholarly InterestsMy laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.
-
Marcelo Fernandez Vina
Professor of Pathology
BioMarcelo Fernández-Viña, Ph.D., D (ABHI) is a Professor for the Department of Pathology at Stanford University Medical School and serves as Director of the Histocompatibility, Immunogenetics and Disease Profiling Laboratory at this institution. He has been working in the fields of Histocompatibility and Immunogenetics since 1982. He earned a degree in Biochemistry from the School of Basic Sciences in Rosario, Argentina, and his Ph.D. in Internal Medicine from the University of Buenos Aires Medical School in Argentina. Previously he held a position as a Professor in the Department of Laboratory Medicine at the University of Texas M.D. Anderson Cancer Center in Houston. He has more than 180 peer reviewed publications, many of them focusing on HLA variation in multiple world populations, identifying susceptibility and resistance factors for diseases and in the impact of HLA mismatches in allogeneic transplantation; and 59 book chapters. He served as expert Consultant for Donor Searches for NMDP and as President Elect, President and Past President of the American Society for Histocompatibility and Immunogenetics. He served as a member of the Board of Directors and the Executive Committee for the United Network for Organ Sharing. He served as Co-Chair of the Immunobiology Committee of the CIBMTR; He also served as a member of the HHS Advisory Council on Blood Stem Cell Transplantation (ACBSCT).He serves as HLA Expert Consultant for the NMDP for the HRSA contract and is a member of the Histocompatibility Advisory Group for NMDP. He is Councilor of the International Histocompatibility Workshop and a member of the WHO Nomenclature Committee for Factors of the HLA System and was Chairman of the (17th) International HLA & Immunogenetics Workshop, and Past President of the International HLA & Immunogenetics Workshop.
-
Sebastian Fernandez-Pol
Clinical Associate Professor, Pathology
BioDr. Sebastian Fernandez-Pol is an academic hematopathologist with fellowship training in hematopathology and dermatopathology. He has a particular interest in improving diagnostic accuracy for cutaneous lymphoproliferative disorders. Dr. Fernandez-Pol received his B.A. in chemistry with a concentration in biochemistry from the Washington University in St. Louis in 2003, his MD and PhD from Northwestern University in 2013, and completed his anatomic pathology and clinical pathology residency, hematopathology fellowship, and dermatopathology fellowship at Stanford University in 2019.
-
Michael S. Fernandopulle
Affiliate, Department Professorship Funds
Resident in PathologyBioMichael Fernandopulle, M.D., Ph.D., is a resident in clinical pathology at Stanford University. During his graduate work at the NIH with Dr. Michael Ward and at Cambridge with Dr. Peter St. George-Hyslop, he uncovered novel pathways for mRNA localization and local protein synthesis in neurons. He is interested in combining biochemistry, metabolism, and high-throughput cell and subcellular profiling technologies to uncover fundamental principles of aging and neurodegeneration, and to apply these discoveries toward novel diagnostics and therapeutics.
Michael holds an Sc.B. in Chemistry from Brown University, an M.D. from Northwestern University, and a Ph.D. in Neuroscience from the University of Cambridge, Darwin College. -
Andrew Fire
George D. Smith Professor of Molecular and Genetic Medicine and Professor of Pathology and of Genetics
Current Research and Scholarly InterestsWhile chromosomal inheritance provides cells with one means for keeping and transmitting genetic information, numerous other mechanisms have (and remain to be) discovered. We study novel cellular mechanisms that enforce genetic constancy and permit genetic change. Underlying our studies are questions of the diversity of inheritance mechanisms, how cells distinguish such mechanisms as "wanted" versus "unwanted", and of the consequences and applications of such mechanisms in health and disease.
-
Ann Folkins
Associate Professor of Pathology
Current Research and Scholarly InterestsDr. Folkins' interest is in gynecologic and obstetric pathology, specifically in ovarian and endometrial malignancies and placental clinical-pathologic disorders.
-
Steven Foung
Professor of Pathology, Emeritus
Current Research and Scholarly InterestsOur research focus is define correlates of protection against hepatitis C virus and other viral pathogens. Detailed characterization of broadly neutralizing human or nonhuman primate monoclonal antibodies against these agents will create high-resolution, functional maps of linear and nonlinear epitopes comprising the major binding sites of both isolate-specific and broadly neutralizing antibodies for rational vaccine design.
-
Susan Galel
Associate Professor of Pathology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsTransfusion-transmitted infections and donor screening for infectious diseases. National policies for blood banks. Enhancement of transfusion safety and effectiveness, with a focus on quality assurance in blood banking and transfusion therapy; transfusion medicine education; pediatric and adult transfusion therapy.
-
Stephen J. Galli, MD
Emeritus Faculty, Academic Council, Pathology
Current Research and Scholarly InterestsThe goals of Dr. Galli's laboratory were to understand the regulation of mast cell and basophil development and function, and to develop and use genetic approaches to elucidate the roles of these cells in health and disease. We studied both the roles of mast cells, basophils, and IgE in normal physiology and host defense, e.g., in responses to parasites and in enhancing resistance to venoms, and also their roles in pathology, e.g., anaphylaxis, food allergy, and asthma, both in mice and humans.
-
Sharon Markham Geaghan
Associate Professor of Pathology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsPediatric Hematopathology, Pediatric Laboratory Medicine and Pathology
-
Andrew Gentles
Associate Professor (Research) of Pathology, of Medicine (Computational Medicine) and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsComputational systems biology
-
Lawrence Tim Goodnough
Professor of Pathology and of Medicine (Hematology), Emeritus
Current Research and Scholarly InterestsImproving blood utilization
Promoting alternatives to blood transfusion
Quality improvements -
Dita Gratzinger
Professor of Pathology
Current Research and Scholarly InterestsI have research interests in the interaction of normal and neoplastic hematolymphoid cells with the bone marrow. lymph node and spleen microenvironment and the interactions of these compartments with immune perturbation and dysregulation.
-
Wei Gu
Assistant Professor of Pathology
Current Research and Scholarly InterestsWe develop breakthrough technologies in molecular testing to advance early and minimally invasive diagnostics. The current focus is a methylation profiling platform using enriched sequencing. One output is the clarification of a patient's tumor type while using less or no tissue (liquid biopsy).
-
Elaheh Hashemi
Postdoctoral Scholar, Pathology
BioI am a postdoctoral researcher specializing in computational biology, bioinformatics, and multi-omics data analysis. My research focuses on integrating single-cell, spatial transcriptomic, and clinical datasets to better understand cellular heterogeneity and disease biology. I am passionate about using computational approaches to uncover biological mechanisms and translate complex datasets into insights that can ultimately improve human health. Outside of research, I enjoy hiking, mountaineering, camping, and playing the piano.
-
Michael Hendrickson
Professor of Pathology at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsDiagnosis of progressive stages of uterine cancer; classification of ovarian tumors; breast cancer diagnosis and prognostic factors, soft tissue neoplasm, uterine mesenchymal neoplasm.
-
Matthew (Matt) Hernandez
Assistant Professor of Pathology (Clinical)
Current Research and Scholarly InterestsDevelopment and optimization of infectious disease diagnostics; microbial genomics and pathogen surveillance; and the interplay between microbial diversity and clinical disease phenotypes.
-
Grant Higerd-Rusli MD, PhD
Resident in Pathology
Current Research and Scholarly InterestsPandemic prevention, diagnosis of emerging infectious diseases.
-
John Higgins
Professor of Pathology
Current Research and Scholarly InterestsI work as a diagnostic surgical pathologist doing translational research in renal neoplasia and medical renal disease and neoplastic and medical liver disease. Subspecialty areas of clinical interest include diagnostic immunohistochemistry, renal, hepatic and transplant pathology.
-
Rory Hills
Postdoctoral Scholar, Pathology
BioI work at the intersection of protein engineering, immunology, and translational medicine. My research focuses on building generalizable molecular tools to better measure and manipulate complex human disease. At Stanford, I am developing modular antibody platforms that enable high-resolution, spatial analysis of cancer and immune systems in intact tissue. I previously trained at Oxford and Cambridge, where I worked on next-generation vaccine platforms with collaborators across academia and industry.
-
Jody Elizabeth Hooper
Professor of Pathology
Current Research and Scholarly InterestsI am the Director of the Research Autopsy Collaboration at Stanford (RACS) to collect organs and tissues from decedent donors for cancer and disease research. https://med.stanford.edu/racs
I have a number of research interests associated with my autopsy work, including how the time interval between death and collection (the PMI) affects the condition and research viability of the collected tissue, how valuable blood and tissue cultures behave after death, and how autopsy results affect clinical practice in an established information loop. I have projects exploring physician and family attitudes towards autopsy and the utilization of rapid autopsy tissue in characterizing cancer evolution from genetic and immunologic standpoints. -
Brooke Howitt
Irene Adler Professor
BioDr. Howitt is a gynecologic and sarcoma pathologist, with academic interests in gynecologic mesenchymal tumors and morphologic and clinical correlates of molecular alterations in gynecologic neoplasia.
-
Michael R. Howitt
Associate Professor of Pathology and of Microbiology and Immunology
Current Research and Scholarly InterestsOur lab is broadly interested in how intestinal microbes shape our immune system to promote both health and disease. Recently we discovered that a type of intestinal epithelial cell, called tuft cells, act as sentinels stationed along the lining of the gut. Tuft cells respond to microbes, including parasites, to initiate type 2 immunity, remodel the epithelium, and alter gut physiology. Surprisingly, these changes to the intestine rely on the same chemosensory pathway found in oral taste cells. Currently, we aim to 1) elucidate the role of specific tuft cell receptors in microbial detection. 2) To understand how protozoa and bacteria within the microbiota impact host immunity. 3) Discover how tuft cells modulate surrounding cells and tissue.
-
Patrick David Hsu
Assistant Professor of Pathology
BioPatrick Hsu is Co-Founder of the Arc Institute and Assistant Professor of Pathology at Stanford University. The Hsu lab works at the intersection of biology and machine learning to develop technologies for biological and therapeutic design. Recent contributions include the Evo series of genome foundation models and the first universally programmable DNA recombinases. Patrick received A.M. and Ph.D. degrees from Harvard University and the Broad Institute of MIT and Harvard, where he was an early pioneer of CRISPR-Cas9 technologies for genome editing. His research has been recognized by awards from the New York Times, The Atlantic, Forbes, MIT Technology Review, Vox, Rainwater Foundation, and Amgen. He serves on the scientific advisory board of Amgen and the board of Stylus Medicine, and cofounded Fast Grants for rapid science funding.
-
Rongting Huang
Postdoctoral Scholar, Pathology
BioDr. Huang is a computational biologist with academic interests in cancer genomics and spatial biology, particularly in the field of gynecologic cancers. During her Ph.D. under the mentorship of Dr. Yuanhua Huang, she developed statistical methods to detect allele-specific somatic copy number variations from single-cell and spatial transcriptomic data, aiming to understand genetic diversity in biological systems. Currently, her research focuses on advancing gynecologic cancer studies and women’s health through spatial technology platforms, computational modeling, and innovative data visualizations to uncover meaningful insights.
Outside of research, she enjoys hiking, rock climbing, and calligraphy, which help her stay creative and balanced. -
Peter K. Jackson
Professor of Microbiology and Immunology (Baxter Labs) and of Pathology
Current Research and Scholarly InterestsDr. Jackson’s lab studies how primary cilia organize hormone, metabolite, and growth factor signaling in metabolic tissues and how their disruption causes obesity and diabetes. A second focus is defining the KRAS driven secreted factor networks that rewire the tumor microenvironment in lung and pancreatic cancers to promote immune evasion and therapeutic resistance. This work is revealing new secreted drug targets and combination strategies for precision oncology and metabolic disease.
-
Siddhartha Jaiswal
Associate Professor of Pathology
Current Research and Scholarly InterestsWe identified a common disorder of aging called clonal hematopoiesis of indeterminate potential (CHIP). CHIP occurs due to certain somatic mutations in blood stem cells and represents a precursor state for blood cancer, but is also associated with increased risk of cardiovascular disease and death. We hope to understand more about the biology and clinical implications of CHIP using human and model system studies.
-
Olena Janczewski
Associate Director of Education, Pathology Ops Business Office
Current Role at StanfordAssociate Director of Education, Pathology
-
Kristin Jensen
Professor of Pathology
Current Research and Scholarly InterestsI am a clinical translational investigator with a primary interest in breast cancer biology, and the use of investigational and clinical ancillary techniques such as gene and tissue microarray analysis and immunohistochemistry in the diagnosis and prognosis of this disease. As a practicing cytopathologist, I also have an interest in improving the fine needle aspiration biopsy diagnosis of breast lesions, again using immunohistochemistry and gene expression analysis as adjuncts to cytomorphology.
-
Rathinaraja Jeyaraj
Postdoctoral Scholar, Pathology
BioI work at the intersection of AI, multimodal learning, and large-scale image analytics, with a strong focus on computational pathology and foundation models for healthcare. My current research interests include LLMs, VLMs, multimodal reasoning, whole-slide image analysis, retrieval-augmented generation (RAG), and trustworthy AI for medical decision support.
I develop scalable deep learning systems spanning WSI preprocessing, multiple instance learning, segmentation, survival prediction, and multimodal image-text modeling. My work also involves attention interpretability, contrastive learning, pathology foundation model adaptation, and large-scale AI pipelines. Beyond healthcare AI, I have experience in time-series forecasting, distributed computing, cloud infrastructure, and real-time computer vision systems for industrial and smart-city applications.
I am particularly interested in building reliable, interpretable, and clinically meaningful AI systems that bridge computer vision, multimodal learning, and large-scale reasoning. -
Neeraja Kambham
Professor of Pathology
Current Research and Scholarly InterestsDr. Kambham's research interests primarily involve medical diseases and transplantation pathology of the kidney and liver.
-
Cansu Karakas
Assistant Professor of Pathology (Clinical Pathology)
BioDr. Cansu Karakas is an Assistant Professor, with subspecialty expertise in Breast Pathology. Her academic career spans notable institutions such as MD Anderson Cancer Center and (2010–2017) and NYU (2017-2018). She is passionate about research with a focus on HER2-driven breast cancers, artificial intelligence (AI) applications in breast cancer and identifying resistance mechanisms to guide novel, personalized therapeutic strategies in breast cancer.
-
Maya M. Kasowski
Assistant Professor of Pathology, of Medicine (Pulmonary, Allergy and Critical Care Medicine) and, by courtesy, of Genetics
BioI am a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. I completed my MD-PhD training at Yale University and my residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. My experiences as a clinical pathologist and genome scientist have made me passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level. The core focus of my lab is to study the mechanisms by which genetic variants influence the risk of disease through effects on intermediate molecular phenotypes.
-
Aditi Khatpe
Postdoctoral Scholar, Pathology
BioAs a Postdoctoral Fellow, I study breast cancer progression and invasion. My research leverages high-dimensional spatial technologies to map cellular architecture and uncover how tumor–stroma interactions influence disease progression. Ultimately, my goal is to translate these insights into strategies that improve diagnosis and treatment.
-
Christina Kong
Professor of Pathology
Current Research and Scholarly InterestsImproving the accuracy of cytologic diagnosis through the use of ancillary techniques on specimens obtained by fine needle aspiration biopsy.
Identifying potential indicators of prognosis in head and neck squamous cell carcinomas.
Evaluating the utility of immunohistochemical stains in refining the diagnosis of squamous dysplasia of the cervix, vulva, and head and neck. -
Christian Kunder
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy main interest is in understanding the biology of human neoplasms, using traditional histopathology, molecular genetic techniques, and other modalities. In particular, I am interested in soft tissue and genitourinary neoplasms, especially prostate cancer.
I am also interested in the classification and nomenclature of neoplasms and in practical research that helps us refine these, using a variety of techniques but still principally guided by histopathology.
I also work on developing next generation sequencing-based tests for genotyping tumors and in expanding the scope of this testing with the goal of identifying patients eligible for novel targeting therapies.
